|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08622 HUAKANG BIOMED
Nominal 
0.640 +0.050 (+8.475%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 12,329 | 3.449% | 25,359 | 24,629 | 25,330 | 26,127 |
| Cost of Sales | (3,913) | -0.407% | (8,287) | (8,536) | (8,416) | (9,671) |
| Gross Profit | 8,416 | 5.345% | 17,072 | 16,093 | 16,914 | 16,456 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (2,369) | 33.165% | (4,158) | (5,782) | (3,007) | (3,903) | |
| Taxation | 0 | -- | 0 | 0 | (68) | (317) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (2,369) | 33.165% | (4,158) | (5,782) | (3,075) | (4,220) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (115) | -10.853% | (426) | (351) | (354) | (77) |
| Depreciation & Amortisation | 1,637 | -5.703% | 3,334 | 3,179 | 3,140 | 2,949 |
| Directors' Emoluments | 1,286 | 25.463% | 2,774 | 2,743 | 2,991 | 2,453 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -0.470 | 23.684% | -0.860 | -1.390 | -0.760 | -1.060 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.006) | 0.000 | 0.003 | (0.006) |
| NBV per share ($) | 0.104 | -- | 0.108 | 0.122 | 0.136 | 0.144 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -2,369 |
| %Change | 33.165% |
| EPS / (LPS) | RMB -0.005 |
| NBV Per Share (¥) | RMB 0.104 |